NERVGEN PHARMA CORP (NGEN.CA) Stock Analyst Ratings
TSX-V:NGEN - CA64082X2032 - Common Stock
3.61 CAD
-0.1 (-2.7%)
ChartMill assigns a Buy % Consensus number of 80% to NGEN.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9. This target is 149.35% above the current price.
NGEN.CA was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NGEN.CA.
In the previous month the buy percentage consensus was at a similar level.
NGEN.CA was analyzed by 8 analysts. More opinions would make the average more meaningful.